Antibody response to routine measles vaccination among a population of Nigerian children and evaluation of vaccine potency
Abstract
Abstract Background: Despite a global decline in mortality and morbidity from measles in the last decade, outbreaks continue to
occur in some parts of the world including Nigeria.
Objective: To determine antibody response to routine measles vaccination in Nigerian children and evaluate vaccine potency.
Methods: A prospective study of 234 children selected from 3 health centres in an urban area of Lagos, Nigeria. Blood was obtained before and 8-12 weeks after routine vaccination with Edmonston- Zagreb strain of measles vaccine. Antibodies were detected using the measles antibody neutralization test. Reconstituted vaccines samples were analysed for potency on monolayers of Vero slam cells in 96-well tissue culture plates.
Results: Twenty seven(11.5%) had pre-vaccination antibodies. Seroconversion rate among the 195 who returned for post vaccination sampling was 69.2%: It was however 74.2% in children with no pre-vaccination antibodies compared to 17.6% in those with antibodies. (p<0.05). Only six (50%) of the measles vaccine vials were potent. Seroconversion rate among subjects vaccinated from potent vials was 74.3% compared with 42.9% in those vaccinated from non-potent vials (p = 0.006).
Conclusion: Seroconversion to measles vaccination in our environment is sub-optimal, partly attributable to low vaccine potency.
Improvement of vaccine handling processes and booster doses of the vaccine are recommended.
Downloads
Published
Issue
Section
License
This is an open-access journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 License, which allows others to remix, transform, and build upon the work even, commercially, as long as appropriate credit is given to the author, and the new creations are licensed under identical terms